{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:34:31Z","timestamp":1789169671572,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111407","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:03:25Z","timestamp":1616526205000},"page":"111407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells"],"prefix":"10.1016","volume":"138","author":[{"given":"Jiezhu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvfen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zele","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2021.111407_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"10177","key":"10.1016\/j.biopha.2021.111407_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111407_bib3","doi-asserted-by":"crossref","unstructured":"A. du Bois, M. Quinn, T. Thigpen, J. Vermorken, E. Avall-Lundqvist, M. Bookman, D. Bowtell, M. Brady, A. Casado, A. Cervantes, E. Eisenhauer, M. Friedlaender, K. Fujiwara, S. Grenman, J.P. Guastalla, P. Harper, T. Hogberg, S. Kaye, H. Kitchener, G. Kristensen, R. Mannel, W. Meier, B. Miller, J.P. Neijt, A. Oza, R. Ozols, M. Parmar, S. Pecorelli, J. Pfisterer, A. Poveda, D. Provencher, E. Pujade-Lauraine, M. Randall, J. Rochon, G. Rustin, S. Sagae, F. Stehman, G. Stuart, E. Trimble, P. Vasey, I. Vergote, R. Verheijen, U. Wagner, I. Gynecologic Cancer, O. Ago, Anzgog, Eortc, Geico, Gineco, Gog, Jgog, Mrc\/Ncri, C.T.G. Ncic, U.S. Nci, Nsgo, Rtog, Sgctg, Igcs, O. Organizational team of the two prior International, 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004), Annals of oncology: official journal of the European Society for Medical Oncology 16 (Suppl 8) 2005, viii7\u2013viii12.","DOI":"10.1093\/annonc\/mdi961"},{"issue":"suppl_8","key":"10.1016\/j.biopha.2021.111407_bib4","doi-asserted-by":"crossref","first-page":"viii36","DOI":"10.1093\/annonc\/mdx450","article-title":"Front-line therapy of advanced epithelial ovarian cancer: standard treatment","volume":"28","author":"Marth","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111407_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0165-6147(92)90048-B","article-title":"Mechanism of action of taxol","volume":"13","author":"Horwitz","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2021.111407_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cellbi.2007.01.004","article-title":"Effects of taxol treatment on the microtubular system and mitochondria of Tetrahymena","volume":"31","author":"Kovacs","year":"2007","journal-title":"Cell Biol. Int."},{"issue":"19","key":"10.1016\/j.biopha.2021.111407_bib7","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1074\/jbc.M900167200","article-title":"Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance","volume":"284","author":"Bhattacharya","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2021.111407_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1535-7163.MCT-05-0190","article-title":"Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules","volume":"5","author":"Hari","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.biopha.2021.111407_bib9","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/cancers7040897","article-title":"Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy","volume":"7","author":"Barbuti","year":"2015","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biopha.2021.111407_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/med.21378","article-title":"Microtubule-binding proteins as promising biomarkers of paclitaxel sensitivity in cancer chemotherapy","volume":"36","author":"Xie","year":"2016","journal-title":"Med Res Rev."},{"issue":"3","key":"10.1016\/j.biopha.2021.111407_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1535-7163.MCT-13-0743","article-title":"Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study","volume":"13","author":"Kathawala","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2021.111407_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/413076","article-title":"Paclitaxel and its evolving role in the management of ovarian","volume":"2015","author":"Kampan","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13045-018-0660-y","article-title":"Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer","volume":"11","author":"Gu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00232-014-9724-2","article-title":"Cisplatin activates volume-sensitive like chloride channels via purinergic receptor pathways in nasopharyngeal carcinoma cells","volume":"248","author":"Yang","year":"2015","journal-title":"J. Membr. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111407_bib15","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1002\/jcb.27274","article-title":"Opening of the CLC-3 chloride channel induced by dihydroartemisinin contributed to early apoptotic events in human poorly differentiated nasopharyngeal carcinoma cells","volume":"119","author":"Zhou","year":"2018","journal-title":"J. Cell Biochem."},{"issue":"14","key":"10.1016\/j.biopha.2021.111407_bib16","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/jm400881m","article-title":"Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities","volume":"56","author":"Liu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111407_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00418-012-0937-0","article-title":"Cell cycle-dependent subcellular distribution of ClC-3 in HeLa cells","volume":"137","author":"Mao","year":"2012","journal-title":"Histochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111407_bib18","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12137","article-title":"Functional expression of chloride channels and their roles in the cell cycle and cell proliferation in highly differentiated nasopharyngeal carcinoma cells","volume":"2","author":"Huang","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2021.111407_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/ar.21392","article-title":"5-Nitro-2-(3-phenylpropylamino) benzoic acid induced drug resistance to cisplatin in human erythroleukemia cell lines","volume":"294","author":"Xu","year":"2011","journal-title":"Anat. Rec."},{"issue":"9","key":"10.1016\/j.biopha.2021.111407_bib20","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/cas.13715","article-title":"Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl(-) \/H(+) transporter inhibition in human breast cancer cells","volume":"109","author":"Fujimoto","year":"2018","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111407_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ar.22665","article-title":"Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy","volume":"296","author":"Su","year":"2013","journal-title":"Anat. Rec."},{"issue":"5","key":"10.1016\/j.biopha.2021.111407_bib22","first-page":"6611","article-title":"Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression","volume":"234","author":"Chen","year":"2019"},{"issue":"2","key":"10.1016\/j.biopha.2021.111407_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3892\/or.2014.3615","article-title":"CLC-3 channels in cancer (review)","volume":"33","author":"Sen","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib24","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00145.2011","article-title":"ClC-3 is a candidate of the channel proteins mediating acid-activated chloride currents in nasopharyngeal carcinoma cells","volume":"303","author":"Wang","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2021.111407_bib25","article-title":"ClC-3 chloride channel proteins regulate the cell cycle by up-regulating cyclin D1-CDK4\/6 through suppressing p21\/p27 expression in nasopharyngeal carcinoma cells","volume":"6","author":"Ye","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2021.111407_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1042\/BCJ20180979","article-title":"Starvation-induced autophagy is up-regulated via ROS-mediated ClC-3 chloride channel activation in the nasopharyngeal carcinoma cell line CNE-2Z","volume":"476","author":"Zheng","year":"2019","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.biopha.2021.111407_bib27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/ijms18081733","article-title":"Taxol\u00ae: the first microtubule stabilizing agent","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111407_bib28","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","article-title":"ZDOCK server: interactive docking prediction of protein\u2013protein complexes and symmetric multimers","volume":"30","author":"Pierce","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.biochem.69.1.277","article-title":"Structural insights into microtubule function","volume":"69","author":"Nogales","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111407_bib30","first-page":"421","article-title":"ClC5 decreases the sensitivity of multiple myeloma cells to bortezomib via promoting pro-survival autophagy","volume":"26","author":"Zhang","year":"2018","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2016.11.033","article-title":"Transcriptional repression of HER2 by ANO1 Cl(-) channel inhibition in human breast cancer cells with resistance to trastuzumab","volume":"482","author":"Fujimoto","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2021.111407_bib32","first-page":"863","article-title":"CLIC1 induces drug resistance in human choriocarcinoma through positive regulation of MRP1","volume":"25","author":"Wu","year":"2017","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"issue":"3","key":"10.1016\/j.biopha.2021.111407_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1158\/1535-7163.MCT-06-0475","article-title":"ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment","volume":"6","author":"Weylandt","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"18","key":"10.1016\/j.biopha.2021.111407_bib34","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.biopha.2021.111407_bib35","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1002\/jcp.27402","article-title":"Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111407_bib36","first-page":"397","article-title":"Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells","volume":"13","author":"Gazitt","year":"1998","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2021.111407_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2017.04.015","article-title":"Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines","volume":"138","author":"Kwon","year":"2017","journal-title":"Biochem. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2021.111407_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13148-018-0459-2","article-title":"The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via \u03b2-catenin\/Cdc25c signaling and G2\/M arrest","volume":"10","author":"Zhang","year":"2018","journal-title":"Clin. Epigenetics"},{"issue":"8","key":"10.1016\/j.biopha.2021.111407_bib39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1242\/jcs.199471","article-title":"The tubulin code at a glance","volume":"130","author":"Gadadhar","year":"2017","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111407_bib40","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/S0021-9258(19)67891-9","article-title":"Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin","volume":"266","author":"Minotti","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2021.111407_bib41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200112086","article-title":"A novel polymer of tubulin forms the conoid of Toxoplasma gondii","volume":"156","author":"Hu","year":"2002","journal-title":"J. Cell Biol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111407_bib42","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"20","key":"10.1016\/j.biopha.2021.111407_bib43","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1073\/pnas.191388598","article-title":"Resistance to taxol in lung cancer cells associated with increased microtubule dynamics","volume":"98","author":"Goncalves","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2021.111407_bib44","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1038\/srep09529","article-title":"Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner","volume":"5","author":"McGrail","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:26:45Z","timestamp":1760099205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"alternative-id":["S075333222100192X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111407","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111407"}}